Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
08/2005
08/10/2005CN1652687A Choline-silicic acid complex with osmolytes and divalent trace elements
08/10/2005CN1651575A Structure of antisense digonucleotide for inhibiting fibronectin expression and use
08/10/2005CN1651565A Production method of aloe lentinus edodes health care wine
08/10/2005CN1651564A Health care wine
08/10/2005CN1651469A Hijiki polysaccharide SFP-I, its separation purification method and application
08/10/2005CN1651433A Salviolic acid berberine double salt, its preparation method and application
08/10/2005CN1651432A Method of refining plamatine from herba fibranreae recisae total ulkuloid and its application
08/10/2005CN1651431A Inhibitors of alpha L beta 2 mediated cell adhesion
08/10/2005CN1651076A Method of extracting rainbow conk saccharide peptide for injection in rainbow conk saccharided peptide crude product obtained from submerged fermentation
08/10/2005CN1651072A Medicine for treating piglet white scour and its preparation method
08/10/2005CN1651065A Notoginseng capsule and its preparation method
08/10/2005CN1651061A Chinese medicine for treating liver disease
08/10/2005CN1651060A Chinese medicine for treating hepatitis B, cirrhosis
08/10/2005CN1651055A Natural life beneficial Chinese medicine
08/10/2005CN1651039A Health care pill for treating apositia
08/10/2005CN1651037A Spleen fortifying food dispersing oral liquid and its preparation method
08/10/2005CN1651034A Ginseng bupleurum drop pill for treating liver disease and its preparation method
08/10/2005CN1651022A Xinxue capsule and its preparation technology
08/10/2005CN1651021A Ginseng royal jelly soft capsule and its preparation process
08/10/2005CN1651000A Liver clearing blood pressure lowering capsule nd its preparation method
08/10/2005CN1650996A Medicinal composition, its preparation method and application
08/10/2005CN1650992A Yinzhi huang capsule, its preparation method and use
08/10/2005CN1650989A Chinese medicine oral cavity adherent emplastrum and its preparation method
08/10/2005CN1650987A Maple knotweed mixture for intestine and stomach hualth and its manufacturing method
08/10/2005CN1650975A Preparation method of compound peach blossom deea tortoise life nourishing agent
08/10/2005CN1650958A Origin nourishing kidney boosting wine and its preparation method
08/10/2005CN1650955A Medicine for treating gastrodynia and its preparation method
08/10/2005CN1650954A Medicine for treating cholangitis and its preparation method
08/10/2005CN1650953A Medicine for treating enteritis diarrhea and its preparation method
08/10/2005CN1650937A Noontime tea volatile oil-beta cyclo dextrin inclusion compound and its preparation technology
08/10/2005CN1650931A Oral agent for dispelling dampness and clearing intestine toxic material and its preparation method
08/10/2005CN1650922A Chinese medicinal composition for treating blood depletion qi vacuity, menstral irregularity and its preparation method
08/10/2005CN1650920A Medicine for treating stomach disease
08/10/2005CN1650916A Chinese medical preparation for treating fullness and pain in stomach duct and abdomen
08/10/2005CN1650915A Medicine for treating spleen-stomach disharmony and increasing appetite and fortifying spleen
08/10/2005CN1650914A Chinese medicinal preparation for treating hepatitis, cholecystitis
08/10/2005CN1650896A Method of extracting gastroenteric power enbancing medicament from natural plant Chinese medicine effective component
08/10/2005CN1650894A Method of extracting compound male moth hidney fortifying raw material possesing improving sexual living quality from pure Chinese medicinal preparation
08/10/2005CN1650893A Health care product for treating intestine duct disease, preparation and use method thereof
08/10/2005CN1650886A Biological product for nourishing stomach, protecting liver, dispelling liquor effect and its manufacturing method
08/10/2005CN1650884A Effervescent agent using medium glycan or/and polysaccharide dief fiber as functional component
08/10/2005CN1650879A Diammonium glycyrrhizate oral cavity disintegrating agent and its preparation method
08/10/2005CN1650878A Inclusion compound of glycyrrhizic acid or its derivative and alkaloid, and its preparation method
08/10/2005CN1650877A Slow release preparation of diammonium glycyrrhizate
08/10/2005CN1650874A Preparation method of oligosaccharide kind health care product
08/10/2005CN1650862A Metaducine dispersion tablet and its preparation method
08/10/2005CN1650861A Medicinal solution for treating ulceration and inflammation
08/10/2005CN1214043C Humanized antibodies to gamma-interferon
08/10/2005CN1214030C Prodrugs of imidazopyridine derivatives, medine containing same and use
08/10/2005CN1214025C Sodium channel modulators derived from 2-piperidylimidazoles
08/10/2005CN1214022C Vitamin D analogues
08/10/2005CN1214017C 四唑衍生物 Tetrazole derivatives
08/10/2005CN1214008C Therapeutic biaryl derivatives
08/10/2005CN1213760C Chinese medicine prepn for treating deficiency of spleen and stomach Yang type atrophic gastritis
08/10/2005CN1213751C Formulation of substituted benzimidazoles
08/10/2005CN1213746C Immunopotentiatory agents and physiologically acceptable salts thereof
08/10/2005CN1213744C Remedies
08/10/2005CN1213742C Pharmaceutical control of inflammation
08/09/2005US6927317 Modulating ramp activity
08/09/2005US6927234 possessing anti-cancer activity, anti-inflammatory activity, anti-obesity activity, and/or hair growth promotion activity
08/09/2005US6927232 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
08/09/2005US6927228 Biphenyl compounds usefuf in treatment of human and veterinary medicines such as dermatology, cardivovascular diseases, immune diseases or diseases associated with lipid metabolisms, or in cosmetic formulation
08/09/2005US6927227 Heterocyclic containing biphenyl aP2 inhibitors and method
08/09/2005US6927224 Anticancer agents; osteoporosis
08/09/2005US6927222 Compounds
08/09/2005US6927221 Tricyclic fused heterocyclic compound, process for preparing it and medicament comprising it
08/09/2005US6927219 Secondary amides such as N-Adamantan-1-methyl-2-chloro-5-(3,5-dioxo-4,5-dihydro-3H- (1,2,4)triazin-2-yl)-benzamide used as antagonists for biological receptors; antiinflammatiory, anticarcinogenic or antiischemic agents
08/09/2005US6926907 Pharmaceutical compositions for the coordinated delivery of NSAIDs
08/09/2005US6926898 Albumin fusion proteins
08/09/2005US6926694 Apparatus and method for delivery of therapeutic and/or diagnostic agents
08/09/2005CA2310627C Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists
08/09/2005CA2256687C Benzimidazole derivatives for treating gastrointestinal inflammatory diseases
08/06/2005CA2553946A1 Antibodies against clostridium difficile toxins and uses thereof
08/04/2005WO2004007457A3 Substituted benzylamine derivatives and methods of use
08/04/2005US20050171361 Production of delta 9 tetrahydrocannabinol
08/04/2005US20050171354 Heterocyclic amines such as (2S,3S)-3-((1R)-6-methoxy-1-methyl -1-trifluoromethylisochroman-7-yl)methylamino-2-phenyl piperidine, used as analgesics, antiinflammatory agents, or for prophylaxis of cardiovascular disorders
08/04/2005US20050171350 Benzhydryl derivatives
08/04/2005US20050171347 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
08/04/2005US20050171346 Proteases, kinases enzyme inhibitors; cardiovascular disorders; central nervous system disorders; antiinflammatrory agents; bone disorders; infections
08/04/2005US20050171345 Pteridine compounds for the treatment of psoriasis
08/04/2005US20050171338 Mammalian tribbles signaling pathways and methods and reagents related thereto
08/04/2005US20050171196 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
08/04/2005US20050171186 3-(1',2'-Dihydro-2'-thioxospiro[cyclohexane-1,3'-[3H]indol]-5'-yl)benzonitrile; 5'-(5-Cyano-1-methyl-1H-pyrrol-2-yl)spiro[cyclohexane-1,3'-[3H]indol]-2'-ylidenecyanamide; progesterone receptor agonist; mixture with estrone (estrogen); hormone replacement therapy, contraception; anticarcinogenic
08/04/2005US20050171183 Indole-type inhibitors of p38 kinase
08/04/2005US20050171178 Exo-1-methyl-1H-imidazole-4-sulfonic acid {3-[6-ethyl-3-(2-hydroxy-indan-2-ylmethyl)-3-aza-bicyclo[3.1.0]hex-6-yl]-phenyl}-amide; opioid receptors (mu, kappa and delta) antagonists; not substrate of the variable enzyme CYP2D6; addiction to an opiates, alcohol; obesity
08/04/2005US20050171174 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
08/04/2005US20050171162 Crystals of benzimidazole compounds
08/04/2005US20050171158 1-(sulfonylaminomethylcarbonyl)-4-cyclohexylpiperidine compounds such as N-[1-(R)-(4-chlorobenzyl)-2-(4-cyclohexyl-4-[1,2,4]triazol-1-ylmethyl-piperidin-1-yl)-2-oxo-ethyl]-methanesulfonamide; various diseases and disorders such as weight control, eating disorders
08/04/2005US20050171153 Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases
08/04/2005US20050171129 Polycyclic guanine derivative phosphodiesterase V inhibitors
08/04/2005US20050171128 Pyrrolo[2,3-d]pyrimidine compounds
08/04/2005US20050171125 Novel alkoxypyridine-derivatives
08/04/2005US20050171123 Quinazoline derivatives as medicaments
08/04/2005US20050171122 Mitotic kinesin inhibitors
08/04/2005US20050171118 Central nervous system, gastrointestinal and psycological disorders; such as 3-(4-chlorobenzenesulfonyl)-2-methyl-7-piperazin-1-yl-1H-indole; synthesis
08/04/2005US20050171117 Preparation of pharmaceutical salts
08/04/2005US20050171111 E.g., 4-[[5-[[4-(3-chlorophenyl)-1,2-dihydro-2-oxo-6-quinolinyl]hydroxymethyl]-1H-imidazol-1-yl]methyl]-benzonitrile; prevents the membrane attachment of p21ras and blocks the aberrant growth of ras-transformed tumors
08/04/2005US20050171106 5'-((benzo)thiophen-1 or 2-yl)spiro[1-azabicyclo[2.2.2]octane-3,2'(3'H)-furo[2,3-b]pyridine] compounds, optionally tritium labeled; binding ligands for nicotinic acetylcholine receptors
08/04/2005US20050171104 Novel thyroid receptor ligands
08/04/2005US20050171101 Neurodegenerative diseases; diseases ascribed by NMDA- and NO-induced neurotoxicity ; ischemia; antiinflammatory; anticancer; antidiabetic; 2-{3-[4-Phenyl-3,6-dihydro-1(2H)-pyridyl]propyl}-6(5H)-phenanthridinone
1 ... 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 ... 1258